Introduction {#s1}
============

Volume control is vital for a cell to respond to its environment. Without volume regulation, vertebrate cells are at the mercy of osmotic imbalance, a property utilized at extremes for biochemical cell lysis. However, by exporting or importing osmolytes in response to environmental or intracellular cues, cells can withstand osmotic stresses and actively regulate volume during cell growth, migration, and death.

Vertebrate cells respond to hypotonic environments by opening channels for chloride and other anions, permitting exchange of diverse osmolytes and requisite water across the membrane to alleviate osmotic imbalance ([@bib11]). The underlying channels, termed volume-regulated anion channels (VRACs) ([@bib21]) have variable selectivity and conductance between cells, but are similarly activated by osmotic stimuli and blocked by small molecule anionic inhibitors including DCPIB (4-\[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy\]butanoic acid) ([@bib6]). While apparently ubiquitous in vertebrate cells, these channels lacked a molecular identity until 2014, when leucine-rich repeat-containing family member 8A (LRRC8A, also named SWELL1) was identified as a required component of VRAC in cells ([@bib24]; [@bib31]). LRRC8A and its paralogs LRRC8B, C, D, and E were proposed to form hexameric ion channels through their homology to Pannexins in the transmembrane helix-containing region ([@bib1]).

VRACs have been implicated in a wide array of physiological and pathophysiological processes including insulin signaling in adipocytes ([@bib32]), neurotransmitter release from astrocytes and brain damage after stroke ([@bib10]; [@bib18]), passage of the chemotherapeutic cisplatin into cancer cells ([@bib23]), and osmotic control during spermatogenesis ([@bib17]). A chromosomal translocation in humans that truncates LRRC8A in the LRR region is associated with the B-cell deficiency agammaglobulinemia ([@bib26]). A mouse knockout of *LRRC8A* exhibits increased mortality and developmental defects in addition to significant defects in T cell development and function ([@bib15]). The broad expression of LRRC8s in vertebrate cells suggests VRACs may have additional, yet-undiscovered, roles in cell biology and physiology.

Functional expression of VRAC in cells requires LRRC8A ([@bib24]; [@bib31]). LRRC8A can form homomeric channels as well as heteromeric channels with its paralogs LRRC8B, C, D and E; channels have been shown to contain one, two, or three different LRRC8 family members ([@bib18]). Channel properties, including ion selectivity and conductance, are modulated by subunit composition and the diversity of native VRAC properties is presumably a consequence of the different combinations of homomeric and heteromeric channels expressed in different cells. For example, LRRC8A homomeric channels exhibit low conductance relative to heteromeric channels ([@bib8]; [@bib13]; [@bib14]; [@bib29]) and only LRRC8AD heteromers readily conduct larger molecules such as cisplatin and the antibiotic blasticidin S ([@bib16]; [@bib23]). Mechanistically, LRRC8 channels can be opened by low cytoplasmic ionic strength, one consequence of hypotonic extracellular environments ([@bib29]; [@bib30]). However, the precise molecular mechanisms for sensing internal ionic strength and transmitting this stimulus to the opening of a channel gate are unknown.

Here, we report structures of the homohexameric LRRC8A channel embedded in lipid nanodiscs in the presence and absence of the inhibitor DCPIB determined by cryo-electron microscopy. The structures reveal the architecture of the LRRC8 family in a membrane environment, the mechanism of channel inhibition by DCPIB, and provide insight into the role of bound lipids in channel organization. Membrane-embedded LRRC8A channels display significant structural heterogeneity, which we resolve into constricted and expanded states. In both states, the LRR domains are conformationally heterogenous. We propose the differences between constricted and expanded states are related to ionic strength sensing and gating conformational changes. We further compare the structures in lipid nanodiscs to structures in the detergent digitonin presented here and in three recent reports ([@bib8]; [@bib13]; [@bib14]). Differences in observed symmetry and LRR conformation between nanodisc-embedded and detergent-solubilized channels suggest an integral role for the membrane environment in LRRC8A structure.

Results {#s2}
=======

Structure of LRRC8A in lipid nanodiscs {#s2-1}
--------------------------------------

LRRC8s are endogenously expressed in vertebrate cells typically used for protein overexpression, so we expressed and purified mouse LRRC8A from *Spodoptera frugiperda* (SF9) insect cells to ensure a homogenous channel preparation for further study ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). To assess the activity of channels from this preparation, we reconstituted LRRC8A purified in detergent into phosphatidylcholine lipids and recorded from proteoliposome patches. As is the case in cells and other reconstituted preparations ([@bib13]; [@bib29]; [@bib30]; [@bib8]), LRRC8 channel activity was only observed in low ionic strength solutions (e.g. 70 mM KCl, [Figure 1A](#fig1){ref-type="fig"}). Channels displayed asymmetric conductance at positive and negative potentials with similar open probability. Purified LRRC8A therefore retains the characteristic properties of homomeric LRRC8A channels in cells: a voltage-dependent conductance activated by low cytoplasmic ionic strength ([@bib13]; [@bib29]).

![Structure of an LRRC8A-DCPIB complex in lipid nanodiscs.\
(**A**) Representative single channel recording from an excised patch containing purified LRRC8A reconstituted into phosphatidyl choline lipids (P~o~ = 0.3, γ = 24 pS at +100 mV; P~o~ = 0.24, γ = 5.4 pS at −100 mV). (B, left) Cryo-EM density of LRRC8A from an unmasked refinement of the constricted state at 4.5 Å resolution and (right) corresponding atomic model viewed from the membrane plane. Individual subunits are alternatingly colored blue and green, nanodisc density is rendered transparent, and LRRs docked into the density are colored gray in the model. Dimensions of the extracellular, transmembrane, linker, and LRR regions are indicated. (**C**) Cryo-EM density of LRRC8A from a LRR masked refinement of the constricted class at 3.21 Å resolution. A view from the membrane (top) and extracellular space (bottom) are shown. One subunit is colored according to region and shown in (**C**) within the density, (**D**) as an isolated model with helices and N-terminus labeled and extracellular domain disulfide bonds depicted in yellow, and (**E**) as a cartoon.](elife-42636-fig1){#fig1}

Initial electron micrographs of LRRC8A solubilized in detergent displayed heterogeneity between particles, especially in the cytoplasmic LRRs ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Inspired by recent reports of differences between structures of membrane proteins determined in lipidic and detergent environments ([@bib5]; [@bib12]; [@bib27]), we pursued high-resolution structures of LRRC8A reconstituted in lipid nanodiscs. To this end, LRRC8A was solubilized and purified in detergent, exchanged into lipid nanodiscs formed by the membrane scaffold protein MSP1E3D1 and phosphatidylcholine lipids (POPC, 1-palmitoyl-2-oleoyl-*sn*-glycero-3-phosphocholine), and vitrified in the presence of the LRRC8 inhibitor DCPIB ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib25]).

[Figure 1B](#fig1){ref-type="fig"} depicts an unmasked reconstruction of LRRC8A-DCPIB in nanodiscs and accompanying model (see [Tables 1](#table1){ref-type="table"} and [2](#table2){ref-type="table"} for cryo-EM data collection and model refinement parameters). LRRC8A forms a 565 kDa, homohexameric channel with each monomer consisting of (from extracellular to intracellular side) an extracellular cap, four transmembrane spanning helices TM1-4, a linker region, and a LRR domain ([Figure 1B--E](#fig1){ref-type="fig"}). Initial reconstructions showed high-resolution features in the extracellular cap and transmembrane spanning regions, but less well resolved and blurred features in the linkers and LRR regions ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). We therefore asked whether distinct conformational states of LRRC8A could be distinguished. Focused classifications on the linker region indeed resolved two channel conformations: a constricted class and an expanded class ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}--[5](#fig1s5){ref-type="fig"}). Significant structural heterogeneity remains in the LRR region within each class. Masking out the LRRs and applying six-fold (C6) symmetry resulted in the highest resolution reconstructions: 3.21 Å resolution for the constricted ([Figure 1C](#fig1){ref-type="fig"}) and 3.32 Å resolution for the expanded class, respectively. These reconstructions enabled de novo model building and refinement for all regions except for the LRR domain ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"} and [7](#fig1s7){ref-type="fig"}), which was instead rigid-body docked into the density from unmasked reconstructions using the high-resolution crystal structure (PDB ID: 6FNW) of this region as a model ([@bib8]).

###### Cryo-EM data collection, processing, refinement, and modeling data for LRRC8A-DCPIB in MSP1E3D1 nanodiscs and LRRC8A in MSP2N2 nanodiscs.

                                              LRRC8A-MSP1E3D1 + DCPIB     LRRC8A-MSP2N2            
  ------------------------------------------- --------------------------- ------------------------ -------------------------------------------------
  Movie \#                                    2482                        2110                     1786
  Magnification                               22,500x                     22,500x                  22,500x
  Voltage (kV)                                300                         300                      300
  Electron exposure (e^--^/Å^2^)              60.8                        55.6                     70.3
  Defocus range (μm)                          −1.2 \~ −2.5                −1.2 \~ −2.5             −1.2 \~ −2.5
  Super resolution pixel size (Å)             0.544                       0.536                    0.536
  Fourier cropped pixel size (Å)              1.088                       1.088                    1.088 (1.149 [Figure 4](#fig4){ref-type="fig"})
  **Processing**                              **Class 1 (constricted)**   **Class 2 (expanded)**   **Class 1 (constricted)**
  Symmetry imposed                            C6                          C6                       C6
  Initial particle images (no.)               752,736                     752,736                  252, 655
  Final particle images (no.)                 25,153                      35,435                   11,507
  Map resolution (umasked, Å)/FSC threshold   3.39/0.143                  3.63/0.143               4.28/0.143
  Map resolution (masked, Å)/FSC threshold    3.21/0.143                  3.32/0.143               4.18/0.143
  **Refinement**                                                                                   
  Model resolution (Å)                        3.52/3.32                   3.81/3.47                4.4/3.8
  FSC threshold                               0.50/0.143                  0.50/0.143               0.50/0.143
  Map-sharpening *B*factor (Å^2^)             −44.538                     −134.6                   −82.8
  Ligands                                     19                          19                       0
  Mean *B* factors (Å^2^)                                                                          
  Protein                                     87.73                       52.17                    152.09
  Ligand                                      65.05                       27.6                     \-
  R.m.s. deviations                                                                                
  Bond lengths (Å)                            0.007                       0.005                    0.004
  Bond angles (°)                             0.775                       0.823                    0.773
  Validation                                                                                       
  MolProbity score                            1.74                        1.94                     1.31
  Clashscore                                  3.34                        4.12                     2.16
  Poor rotamers (%)                           3.09                        3.17                     0.69
  EMRinger score                              2.7                         2.2                      0.7
  Ramachandran plot                                                                                
  Favored (%)                                 96.42                       94.67                    95.44
  Allowed (%)                                 3.58                        5.33                     4.56
  Disallowed (%)                              0                           0                        0.69

###### Cryo-EM data collection information for the digitonin datasets used in [Figure 2A](#fig2){ref-type="fig"} and [Figure 4](#fig4){ref-type="fig"}.

  Data collection                   Digitonin 70 mM KCl   Digitonin 150 mM KCl   Digitonin 600 mM KCl
  --------------------------------- --------------------- ---------------------- ----------------------
  Movie \#                          2550                  1445                   1464
  Magnification                     22,500x               22,500x                22,500x
  Voltage (kV)                      300                   300                    300
  Electron exposure (e^--^/Å^2^)    60.8                  55.6                   55.6
  Defocus range (μm)                −1.2 \~ −2.5          −1.2 \~ −2.5           −1.2 \~ −2.5
  Super resolution pixel size (Å)   0.536                 0.544                  0.544
  Fourier cropped pixel size (Å)    1.088                 1.088                  1.088

DCPIB inhibits LRRC8A through a cork-in-bottle mechanism {#s2-2}
--------------------------------------------------------

The extracellular cap of LRRC8A is formed by the TM1-TM2 and TM3-TM4 connections from each chain, which pack into a compact domain consisting of a three-stranded beta sheet (ES1-3) and short alpha helix EH1 stabilized by three intra-chain disulfide bonds ([Figure 1D,E](#fig1){ref-type="fig"}). The subunits associate to form a tube extending \~25 Å above the membrane surface with the inner surface of the tube formed by helix EH1. The N-terminal arginine residue of this helix (R103) projects in towards the conduction axis to form the highly electropositive selectivity filter ([@bib8]) of the anion-selective channel ([Figure 2](#fig2){ref-type="fig"}). The electropositive character in this region is also contributed by the helical dipole of EH1 projecting toward the conduction pathway.

![DCPIB inhibitor binding site.\
(**A**) Representative side-view two-dimensional class averages of LRRC8A (left) solubilized in digitonin, (middle) reconstituted in MSP2N2 lipid nanodiscs, or (right) MSP1E3D1 lipid nanodiscs and complexed with DCPIB. An arrow highlights the bi-lobed feature corresponding to DCPIB in the channel selectivity filter. (**B**) Cryo-EM density maps of the LRRC8A selectivity filter in (left) MSP2N2 nanodiscs or (right) MSP1E3D1 nanodiscs with DCPIB. The DCPIB binding region is highlighted in white boxes for each map. (**C**) View of the selectivity filter with bound DCPIB from (left) the extracellular solution (top view) and (middle) the membrane plane (side view). The atomic model is shown as ribbons and sticks within the cryo-EM density with the two front and two rear subunits removed in the side view for clarity. Nitrogens are colored blue, oxygens red, chlorines green, protein carbons gray, and DCPIB carbons teal. Alignment of the residues surrounding the selectivity filter for LRRC8 paralogs is shown below the drug density with numbering for LRRC8A above. (right) The chemical structure of DCPIB. (**D**) Views of the DCPIB-binding site as in (**B**), but with the atomic surface colored by electrostatic potential from electronegative red (−5 k~b~Te~c~^−1^) to electropositive blue (+5 k~b~Te~c~^−1^), with the color scale drawn on the left panel.](elife-42636-fig2){#fig2}

A prominent density in the reconstruction, visible even in two-dimensional class averages, is a champagne cork-shaped feature found within and immediately above the R103 ring ([Figure 2A](#fig2){ref-type="fig"}). We attribute this bi-lobed density to the DCPIB inhibitor based on size, shape, chemical considerations, and comparison to apo-LRRC8A reconstructions ([Figure 2A](#fig2){ref-type="fig"} and below). Attempts to visualize a single binding pose for DCPIB by focused refinement, asymmetric refinement, or symmetry expansion were unsuccessful. Therefore, the density in our maps represents a six-fold average of positions adopted by DCPIB in different particles ([Figure 2B,C](#fig2){ref-type="fig"}). The density is well fit with the predominantly hydrophobic indane, butyl, and cyclopentyl constituents in the larger lobe extracellular to the R103 ring and the negatively charged butanoic acid group in the smaller lobe adjacent to and below the guanidinium groups of the R103 ring. In this way, the electronegative portion of DCPIB interacts favorably with the electropositive arginine side chains ([Figure 2C](#fig2){ref-type="fig"}). The connection between the two lobes corresponds to the ester linkage between the indane and butanoic acid. The weaker density for this region is presumably due to it adopting different conformations in different particles and the imposed six-fold symmetry.

To increase our confidence in the modeled DCPIB-binding site, we asked whether similar density features could be observed in apo-LRRC8A structures. We determined the structure of apo-LRRC8A in MSP2N2 nanodiscs and POPC lipids in a constricted conformation to 4.18 Å resolution ([Figure 1---figure supplement 8](#fig1s8){ref-type="fig"}--[10](#fig1s10){ref-type="fig"} and [Figure 2A,B](#fig2){ref-type="fig"}). Two-dimensional class averages and the final map of apo-LRRC8A lack the strong bi-lobed density along the conduction axis near the R103 ring attributed to DCPIB in drug-bound LRRC8A ([Figure 2A,B](#fig2){ref-type="fig"}). This density is similarly absent from four separate reconstructions of apo-LRRC8A in detergent: a low-resolution reconstruction presented here ([Figure 2A](#fig2){ref-type="fig"}) and three independently determined to higher resolution ([@bib8]; [@bib13]; [@bib14]).

The structure of DCPIB bound to LRRC8A provides a simple explanation for the mechanism of drug block: DCPIB acts like a cork to plug the mouth of the channel. The R103 ring electrostatically interacts with the DCPIB carboxylic acid while the bulky hydrophobic end of the drug is too large to pass. Ion conduction is thus prevented by an obstructed selectivity filter. DCPIB universally blocks LRRC8 currents even though amino acids around the inhibitor binding site in LRRC8A (including R103) are not strictly conserved in LRRC8A paralogs ([Figure 2B](#fig2){ref-type="fig"}, right). However, since all functional LRRC8 channels contain LRRC8A subunits, similar drug-LRRC8A interactions could account for block of heteromeric channels. Consistent with this model of channel inhibition by anionic small molecules, an R103F mutation in LRRC8A that renders the selectivity filter ring apolar in heteromeric LRRC8AC channels eliminates extracellular block by 1 mM ATP ([@bib14]). Electrostatic and steric complementarity around the R103 ring are therefore important determinants of LRRC8 block by anionic inhibitors.

Constricted and expanded structures provide a mechanism to relay conformational changes between an ionic strength sensor and channel gate {#s2-3}
-----------------------------------------------------------------------------------------------------------------------------------------

Focused classification on the linker region and lower portion of the TMs resolved a constricted and an expanded state of LRRC8A ([Figure 3A](#fig3){ref-type="fig"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). The structure of the extracellular cap, DCPIB-bound selectivity filter, and extracellular halves of the TM region are essentially indistinguishable between the two structures (mean Cα r.m.s.d. = 0.42 Å). Alignment of the two structures by the extracellular cap shows that the differences are confined to the cytoplasmic halves of the TMs, linker regions, and LRRs. The differences can be approximated as a rigid body displacement of the lower portion of the channel about hinges approximately half way through each transmembrane helix. This generates displacements of \~2--4 Å in the cytoplasmic ends of the transmembrane helices, the linkers, and at the cytoplasmic connection between the linkers and LRRs ([Figure 3B--D](#fig3){ref-type="fig"}). As a consequence of these conformational changes, the channel cavity is markedly larger in the expanded state: it dilates approximately 4 Å including at the first resolved N-terminal residue (Pro15) ([Figure 3B](#fig3){ref-type="fig"} and [Videos 1](#video1){ref-type="video"} and [2](#video2){ref-type="video"}).

![Constricted and expanded LRRC8A structures.\
(**A**) Overlay of constricted (blue) and expanded (red) structures of LRRC8A viewed from the membrane with two opposing subunits shown for each structure in ribbon representation. DCPIB is shown in grey sticks. Proline 15, the final modeled residue at the N-terminus, is labeled. (**B**) Comparison of the pore radius along the conduction axis colored as in (**A**). (**C**) Close-up view of the structure overlay at the linker region with models drawn as cartoons. Helices are labeled and distances between Cα positions at the following positions are indicated: NT, R18; LH1, K162; LH2, T170; LH3, K249; LH4, I356; LH5, S379; LH6, S387; LH7, E399. (**D**) Overlay of unmasked cryo-EM maps from constricted and expanded particles showing correlated movement of the linker region and membrane-proximal LRR region. Density within 5 Å of two opposing chains is shown.](elife-42636-fig3){#fig3}

###### Motion of two opposing chains (as in [Figure 3A](#fig3){ref-type="fig"}) as a cartoon-representation morph between constricted and expanded states.

Measurement in Å between the C-alpha of Pro15 is included.

###### Linker region (as in [Figure 3C](#fig3){ref-type="fig"}) motion as a cartoon-representation morph between constricted and expanded states.

Importantly, the presence of the two conformations is not a consequence of drug-binding or imposed symmetry in reconstructions. The two states are comparably populated in apo-LRRC8A and DCPIB-bound nanodisc datasets classified with three different approaches ([Figure 4---figure supplements 1](#fig4s1){ref-type="fig"},[2](#fig4s2){ref-type="fig"}) and structures of constricted classes from apo-LRRC8A and DCPIB-bound LRRC8A in nanodiscs are not significantly different in the extracellular, transmembrane, and linker regions (mean Cα r.m.s.d. = 0.32 Å, [Figure 1---figure supplement 9D](#fig1s9){ref-type="fig"}).

Might the differences between constricted and expanded states be related to gating conformational changes? Gating in LRRC8 and related connexin and innexin channels involves the N-terminus prior to the beginning of TM1 ([@bib14]; [@bib22]; [@bib34]), whereas sensing of internal ionic strength is thought to occur in the cytoplasmic LRRs or connection between linker helices 2 and 3 ([@bib29]). Notably, the conformational changes we observe between constricted and expanded states couple these presumed sensing and gating elements. The extreme N-terminus of LRRC8A (amino acids 1--14) is not resolved in our structures (or in detergent-solubilized LRRC8A structures \[[@bib8]; [@bib13]; [@bib14]\]) presumably due to flexibility that results in heterogeneity between particles. However, amino acids 15--21 are visible and form a helical extension of TM1 that projects toward the center of the channel ([Figure 3A and B](#fig3){ref-type="fig"}). This region is coupled through the linkers to the LRRs via an elbow formed by the N-terminal helix, TM1, and LH5 ([Figure 3C](#fig3){ref-type="fig"}). The conformational changes we observe show how expansion of cytoplasmic ionic-strength sensing regions can be coupled to expansion of N-terminal gating regions and the channel pore. Whether these changes are alone sufficient to gate the channel or rather represent intermediates along a pathway of larger gating conformational changes depends in part upon the position of extreme N-terminus.

Channel symmetry and heterogeneity of LRRs in nanodiscs {#s2-4}
-------------------------------------------------------

Recent structures of LRRC8A in digitonin showed an unexpected three-fold symmetric trimer of dimers arrangement with pairs of LRRC8A subunits forming an asymmetric unit of the channel ([@bib8]; [@bib13]; [@bib14]). Strikingly, LRRC8A in lipid nanodiscs does not display this arrangement. Instead, we observe six-fold symmetric channels with conformationally heterogeneous LRRs.

Structural heterogeneity in LRRs of particles in lipid nanodiscs is readily apparent in 2D class averages ([Figure 4A](#fig4){ref-type="fig"}, [Videos 3](#video3){ref-type="video"} and [4](#video4){ref-type="video"}). Side views of the particles constituting both constricted and expanded classes display a range of LRR positions: LRRs are closely packed underneath the linker region in some classes and splayed laterally away from the conduction axis in others. As expected from the two-dimensional classes, three-dimensional reconstructions with or without symmetry enforced, or using masking strategies to isolate the LRRs, generated low-resolution features for this region. We conclude that LRRs of LRRC8A-DCPIB in lipid nanodiscs can access a large conformational space. Interestingly, comparison of two-dimensional class averages of apo-LRRC8A and DCPIB-bound LRRC8A in nanodiscs shows an apparent increase in the conformational space sampled by the LRRs in the presence of DCPIB ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Still, the average position of membrane proximal region of the LRRs adopts a more constricted or expanded position in the corresponding structure class, about which there appears to be similar heterogeneity ([Figure 3D](#fig3){ref-type="fig"} and [Figure 4A](#fig4){ref-type="fig"}).

![LRR position and channel symmetry differences in lipid and detergent environments.\
(**A**) Side-views of two-dimensional class averages from the (top) constricted and (bottom) expanded particle classes illustrating variation in LRR position. Also see [Videos 3](#video3){ref-type="video"} and [4](#video4){ref-type="video"}. (**B**) Symmetry comparison of LRRC8A in (left) MSP1E3D1 + DCPIB, (middle) digitonin, or (right) MSP2N2 (displayed at a 0.015 threshold). Selected classes from three-dimensional classing jobs with the indicated symmetry are shown from the side (membrane) or bottom (cytoplasm).](elife-42636-fig4){#fig4}

###### Constricted state side-views of LRRC8A-DCPIB in MSP1E3D1 nanodiscs illustrating heterogenous LRR positions.

###### Expanded state side-views of LRRC8A-DCPIB in MSP1E3D1 nanodiscs illustrating heterogenous LRR positions.

We used four approaches to assess the symmetry of LRRC8A in lipid nanodiscs. First, we subjected LRRC8A-nanodisc particle stacks (generated without imposing symmetry) to classification without symmetry (C1), with three-fold (C3), or with six-fold (C6) symmetry imposed ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}). Reconstructions without imposed symmetry have six-fold symmetric features, including in the linker region where individual subunits are oriented and spaced uniformly, that are recapitulated with improved definition and resolution when three- and six-fold symmetry is imposed. Second, the final LRRC8A-nanodisc particles used for high-resolution reconstructions (generated with C6-symmetry imposed and LRRs masked) were refined with C1, C3, or C6 symmetry. Again, C1 reconstructions display features with six-fold symmetry and imposing C3 and C6 symmetry improves these map features. Third, we attempted to identify a class of C3 symmetric particles in nanodiscs using references made from reported C3-symmetric structures of LRRC8A in digitonin. This approach failed to generate high-resolution reconstructions with or without masking of the LRRs. Finally, we performed symmetry expansion of refined particles and subjected them to asymmetric classification without alignment. This approach results in similar approximate six-fold symmetric reconstructions. We therefore conclude that LRRC8A-DCPIB in nanodiscs is six-fold symmetric outside of the heterogeneous LRRs.

To determine whether differences between nanodisc and digitonin structures are related to different hydrophobic environments, drug binding, or other factors, we performed analogous analyses of apo-LRRC8A in MSP2N2 nanodiscs and apo-LRRC8A in digitonin ([Figure 4B](#fig4){ref-type="fig"} and [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}). Drug binding had no effect on symmetry or overall channel structure apart from increasing the conformational space sampled by the LRRs ([Figure 4](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). In contrast, apo-LRRC8A particles in digitonin display three-fold symmetry with compact LRRs (i.e. a trimer-of-dimers arrangement), consistent with published structures ([@bib8]; [@bib13]; [@bib14]). Thus, the presence of DCPIB, choice of scaffold protein, or expression host are unlikely to generate structural and symmetry differences in LRRC8A. Instead, we conclude that the hydrophobic environment surrounding LRRC8A is a key determinant of channel structure: digitonin micelles promote three-fold channel symmetry and compact LRRs while lipid bilayers promote six-fold symmetric channels with asymmetric and conformationally heterogeneous LRRs.

How might the differences between digitonin and lipid bilayers influence the structure of LRRC8A channels? A conspicuous feature of LRRC8A is the presence of gaps between subunits that create lipid-facing crevasses in the channel surface. In lipid nanodiscs, a large lower gap and a smaller upper gap are separated by a constriction made by amino acids Leu131 and Phe324. The upper gap is filled with three well-defined tubular features that are modeled as partial POPC lipid hydrocarbon acyl chains ([Figure 5](#fig5){ref-type="fig"}). The presence of these ordered acyl chains seals the upper gap in the channel surface and may act as a 'glue' that connects adjacent subunits and stabilizes the upper transmembrane domain against movements in channel linkers and LRRs. In the C3-symmetric LRRC8A structures in digitonin ([@bib13]; [@bib14]), there are two distinct subunit interfaces -- one with a narrow separation and one with a wider separation between neighboring chains ([Figure 6](#fig6){ref-type="fig"} and [Videos 5](#video5){ref-type="video"} and [6](#video6){ref-type="video"}). This results in a striking rearrangement of the lipid-binding site. In nanodiscs, the upper gap tapers to a tunnel ideally sized to surround the central bound acyl chain (5--6 Å in diameter). In detergent, in contrast, this gap becomes either too large to optimally accommodate an acyl chain (6.9--7.3 Å diameter in the wide interface) or too small for one to fit (4.1 Å diameter in the narrow interface). Consistently, density for lipids is not observed in LRRC8A-digitonin reconstructions. In one map, a feature consistent with a digitonin molecule is wedged between subunits near the wide-interface upper gap instead ([Figure 6C](#fig6){ref-type="fig"}) ([@bib14]). This suggests an explanation for the differences between LRRC8A structures: when lipid surrounding the channel is removed, the channel adapts from six evenly spaced lipid-filled gaps to three smaller gaps incompatible with lipid binding and three larger gaps perhaps filled with digitonin. These changes at subunit interfaces in the transmembrane region are propagated through the structure to influence overall channel structure and symmetry.

![LRRC8A-lipid interactions.\
(**A**, above) Surface representation of the constricted LRRC8A class viewed from the membrane with docked POPC lipid chains depicted in stick (tan) and space-filling (transparent) representations. The upper gap between subunits is filled by lipid density and an asterisk marks the larger lower gap. (Below) a zoomed-in view on the upper gap and bound lipid. (B, above) The corresponding cryo-EM density viewed as in (**A**), with lipid and the nearby hydrophobic amino-acid side chains shown in stick form. (Below), a zoomed-in view with the amino acids of the hydrophobic pocket labeled.](elife-42636-fig5){#fig5}

![Differences in LRRC8A structures solved in lipid bilayers and detergent micelles.\
Overlays of extracellular domain-aligned models of the constricted state structure determined in lipid nanodiscs (gray) and the (left) narrow and (middle) wide subunit interfaces from structures determined in digitonin: (A, PDB: 5zsu, green \[[@bib13]\]), (B, PDB: 6djb, blue \[[@bib14]\]). Boxed and zoomed in regions (right) illustrate the expansion in subunits of the wide interfaces extending to the LRR region. Distances between V34 and L131 Cαs in detergent-solubilized structures are indicated. (C) Aligned density between the six-fold symmetric constricted state in nanodiscs (gray) and LRRC8A in digitonin (Blue, EMDB: 7935, \[[@bib14]\]). (left) View from the membrane of the narrow C3 subunit interface. (middle) View from the membrane of the wide C3 subunit interface. Boxed region and zoomed-in panels (right) show the upper gap filled with lipid density in nanodiscs or an extra density consistent with digitonin in the wide interface marked by a white arrow.](elife-42636-fig6){#fig6}

###### Overlay of the constricted state and narrow and wide interfaces of PDB: 6djb.

###### Overlay of the constricted state and narrow and wide interfaces of PDB: 5zsu.

Discussion {#s3}
==========

The nanodisc-embedded LRRC8A-DCPIB structures presented here provide the first insights into drug block of LRRC8 channels or related connexin and innexin channels. DCPIB binding in the channel selectivity filter is largely dictated by size and electrostatic complementarity of the small molecule and channel. The DCPIB-binding site appears to be relatively rigid; there are no detectable conformational changes in the extracellular cap, transmembrane region, or linkers between drug-free and DCPIB-bound constricted state structures and no detectable changes in cap structure between any structure in nanodisc or detergent (although we can not rule out the possibility of changes in the cap of expanded state apo-LRRC8A in nanodiscs in the absence of a high-resolution reconstruction). We note that in nanodiscs, drug binding does appear to increase conformational heterogeneity of LRRs in two-dimensional class averages, suggesting the possibility of allosteric communication between the cytoplasmic and extracellular regions. The functional ramifications of this increase in LRR flexibility, if any, remain to be determined. The small LRRC8A-drug interface likely primarily accounts for the relatively modest (low micromolar) affinity of DCPIB for LRRC8 channels ([@bib6]). This is also consistent with the broad target profile of DCPIB; in addition to inhibiting LRRC8 homomeric and heteromeric channels, it inhibits connexin hemichannels ([@bib3]). The structures reported here provide a platform for future structure-based design of inhibitors with higher affinity or more restricted target range, perhaps by increasing the drug-channel interface size and complementarity in the extracellular cap. Improved pharmacology would likely help to both refine proposed and define new physiological roles for LRRC8 channels.

The correlated changes in the N-terminal region, linker, and LRRs in the constricted and expanded states suggest a mechanism to transmit information from the ionic strength sensor to the channel gate. To our knowledge, there is currently no experimental evidence that supports a model in which the expanded state is more open than the constricted state (or vice versa). Still, it is tempting to speculate based on structural considerations that the expanded state represents an intermediate on the path to a fully conductive channel. The 4 Å increase in channel cavity diameter at the position of the unresolved N-terminus represents a significant expansion, comparable in size to the selectivity filter opening and approaching the diameter of a solvated chloride ion. Still, we cannot determine whether these changes are sufficient to fully open the channel since the N-terminal 14 amino acids that project into the channel cavity are unresolved. Since the particles are vitrified in an ionic strength that would correspond to closed or inactivated channels (150 mM KCl), additional conformational changes might be expected to fully open the channel. One possibility is that a dynamic N-terminal region creates an entropic barrier to ion passage in nonconductive channels and gating by low ionic strength involves conformational changes that order the N-terminus to create a favorable environment for anion conduction.

Intriguingly, both the symmetry changes and conformational flexibility of the LRRs are reminiscent of the unrelated bacterial CorA channel ([@bib8]; [@bib14]; [@bib20]). In CorA, loss of intracellular Mg^2+^ binding allows intracellular domains to move outward and adopt an asymmetric conformation that promotes conduction. It is not known how LRRC8A senses reduced internal ionic strength. It may be that specifically bound ions promote the closed state in physiological ionic strength. Alternatively, polar or ionic protein interactions could be stabilized when ionic strength is sufficiently high to provide charge screening. In either case, reduced ionic strength may result in loss of interactions between cytoplasmic LRRs and/or linker helix 2--3 connections that otherwise promote a compact structure and constricted pore. This could allow an expansion in cytoplasmic regions that is relayed through the linkers to dilate and open the channel. Future studies that define conductive LRRC8 structures and correlate channel motions with functional states will help to further elucidate ionic-strength sensing and gating mechanisms of this dynamic and prolific vertebrate channel family.

Data availability {#s3-1}
-----------------

Final maps of LRRC8A-DCPIB in MSP1E3D1 nanodiscs have been deposited to the Electron Microscopy Data Bank under accession codes EMDB-0562 (masked constricted state) and EMDB-0563 (masked expanded state). Atomic coordinates have been deposited in the PDB under IDs 6NZW (constricted state) and 6NZZ (expanded state). The original micrograph movies have been deposited to EMPIAR under accession codes EMPIAR-10258 and EMPIAR-10259. The map of apo-LRRC8A in MSP2N2 nanodiscs in a constricted state has been deposited with EMDB accession code EMDB-0564 and coordinates deposited in the PDB with ID 6O00.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                         Designation                 Source or reference                                                                                                    Identifiers                                                    Additional\
  (species) or resource                                                                                                                                                                                                                                   information
  ------------------------------------- --------------------------- ---------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------
  Gene (*Mus musculus*)                 LRRC8A                      Gen9 synthesis                                                                                                         Uniprot: Q80WG5                                                Codon-optimized for *Spodoptera*\
                                                                                                                                                                                                                                                          *frugiperda*

  Cell Line (*Spodoptera frugiperda*)   Sf9                         Expression Systems                                                                                                     Catalog Number: 94--001F                                       

  Peptide,\                             MSP1E3D1                    Prepared as described in doi: [10.1016/S0076-6879(09)64011--8](http://doi.org/10.1016/S0076-6879(09)64011%E2%80%938)                                                                  His-tag cleaved
  recombinant protein                                                                                                                                                                                                                                     

  Peptide, recombinant\                 MSP2N2                      Prepared as described in doi: [10.1016/S0076-6879(09)64011--8](http://doi.org/10.1016/S0076-6879(09)64011%E2%80%938)                                                                  His-tag cleaved
  protein                                                                                                                                                                                                                                                 

  Chemical\                             DDM                         Anatrace                                                                                                               Part Number: D310S                                             
  compound, drug                                                                                                                                                                                                                                          

  Chemical\                             CHS                         Anatrace                                                                                                               Part Number: CH210                                             
  compound,\                                                                                                                                                                                                                                              
  drug                                                                                                                                                                                                                                                    

  Chemical\                             Digitonin                   EMD Chemicals                                                                                                          CAS 11024-24-1                                                 
  compound,\                                                                                                                                                                                                                                              
  drug                                                                                                                                                                                                                                                    

  Chemical\                             16:0-18:1 PC (POPC) lipid   Avanti Polar Lipids                                                                                                    SKU: 850457C                                                   
  compound, drug                                                                                                                                                                                                                                          

  Chemical compound, drug               DCPIB                       Tocris                                                                                                                 CAS Number: 82749-70-0, Catalog Number: 1540                   

  Software, algorithm                   RELION                      doi: [10.7554/eLife.42166](http://doi.org/10.7554/eLife.42166)                                                         Relion 3.0                                                     

  Software, algorithm                   Gctf                        doi: [10.1016/j.jsb.2015.11.003](http://doi.org/10.1016/j.jsb.2015.11.003)                                             Gctf v1.06                                                     

  Software,\                            UCSF Chimera                UCSF                                                                                                                   RRID:[SCR_004097](https://scicrunch.org/resolver/SCR_004097)   <http://plato.cgl.ucsf.edu/chimera/>
  algorithm                                                                                                                                                                                                                                               

  Software,\                            COOT                                                                                                                                               RRID:[SCR_014222](https://scicrunch.org/resolver/SCR_014222)   <http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>
  algorithm                                                                                                                                                                                                                                               

  Software,\                            Phenix                                                                                                                                             RRID:[SCR_014224](https://scicrunch.org/resolver/SCR_014224)   [https://www.](https://www.phenix-online.org/)\
  algorithm                                                                                                                                                                                                                                               [phenix-online.org/](https://www.phenix-online.org/)

  Software,\                            PyMOL                       PyMOL MolecularGraphicsSystem, Schrodinger\                                                                            RRID:[SCR_000305](https://scicrunch.org/resolver/SCR_000305)   <https://www.pymol.org/>
   algorithm                                                        LLC                                                                                                                                                                                   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Protein expression {#s4-1}
------------------

The coding sequence for LRRC8A from *Mus musculus* was codon optimized for *Spodoptera frugiperda* and synthesized (Gen9, Cambridge, MA). The sequence was then cloned into a custom vector based on the pACEBAC1 backbone (MultiBac; Geneva Biotech, Geneva, Switzerland) with an added C-terminal PreScission protease (PPX) cleavage site, linker sequence, superfolder GFP (sfGFP) and 7xHis tag, generating a construct for expression of mmLRRC8A-SNS-LEVLFQGP-SRGGSGAAAGSGSGS-sfGFP-GSS-7xHis. MultiBac cells were used to generate a Bacmid according to manufacturer's instructions. *Spodoptera frugiperda* (Sf9) cells were cultured in ESF 921 medium (Expression Systems, Davis, CA) and P1 virus was generated from cells transfected with Cellfectin II reagent (Life Technologies, Carlsbad, CA) according to manufacturer's instructions. P2 virus was then generated by infecting cells at 2 million cells/mL with P1 virus at an MOI \~ 0.1, with infection monitored by fluorescence of sfGFP-tagged protein and harvested at 72 hr. P3 virus was generated in a similar manner to expand the viral stock. The P3 viral stock was then used to infect 1 L of Sf9 cells at 4 million cells/mL at an MOI \~ 2--5. At 72 hr, infected cells containing expressed LRRC8A-sfGFP protein were harvested by centrifugation at 2500 x g and frozen at −80°C.

Protein purification {#s4-2}
--------------------

Cells from 1 L of culture (\~15--20 mL of cell pellet) were thawed in 100 mL of Lysis Buffer containing (in mM) 50 HEPES, 150 KCl, 1 EDTA pH 7.4. Protease inhibitors (Final Concentrations: E64 (1 µM), Pepstatin A (1 µg/mL), Soy Trypsin Inhibitor (10 µg/mL), Benzimidine (1 mM), Aprotinin (1 µg/mL), Leupeptin (1 µg/mL), and PMSF (1 mM)) were added to the lysis buffer immediately before use. Benzonase (4 µl) was added after cell thaw. Cells were then lysed by sonication and centrifuged at 150,000 x g for 45 min. The supernatant was discarded and residual nucleic acid was removed from the top of the membrane pellet using DPBS. Membrane pellets were scooped into a dounce homogenizer containing Extraction Buffer (50 mM HEPES, 150 mM KCl, 1 mM EDTA, 1% n-Dodecyl-β-D-Maltopyranoside (DDM, Anatrace, Maumee, OH), 0.2% Cholesterol Hemisuccinate Tris Salt (CHS, Anatrace) final pH 7.4). A 10%/2% solution of DDM/CHS was dissolved and clarified by bath sonication in 200 mM HEPES pH eight prior to addition to buffer to the indicated final concentration. Membrane pellets were then homogenized in Extraction Buffer and this mixture (150 mL final volume) was gently stirred at 4°C for 3 hr. The extraction mixture was centrifuged at 33,000 x g for 45 min and the supernatant, containing solubilized membrane protein, was bound to 4 mL of sepharose resin coupled to anti-GFP nanobody for 1 hr at 4°C. The resin was then collected in a column and washed with 10 mL of Buffer 1 (20 mM HEPES, 150 mM KCl, 1 mM EDTA, 0.025% DDM, pH 7.4), 40 mL of Buffer 2 (20 mM HEPES, 500 mM KCl, 1 mM EDTA, 0.025% DDM, pH 7.4), and 10 mL of Buffer 1. The resin was then resuspended in 6 mL of Buffer 1 with 0.5 mg of PPX and rocked gently in the capped column for 2 hr. Cleaved LRRC8A protein was then eluted with an additional 8 mL of Wash Buffer, spin concentrated to \~500 µl with Amicon Ultra spin concentrator 100 kDa cutoff (Millipore), and then loaded onto a Superose 6 Increase column (GE Healthcare, Chicago, IL) on an NGC system (Bio-Rad, Hercules, CA) equilibrated in buffer 1. Peak fractions containing LRRC8A channel were then collected and spin concentrated.

Purification in digitonin was performed analogously with the following modifications. Tris buffer was used instead of HEPES buffer during purification. Washing and cleavage steps were carried out in 0.1% DDM and 0.02% CHS and cleavage was performed overnight. Digitonin (EMD Chemicals Inc, San Diego, CA) Buffer containing 20 mM Tris, (70, 150, or 600) mM KCl, 1 mM EDTA, 0.05% Digitonin (final pH 8) was prepared by dissolving digitonin in buffer at room temperature, cooling buffer to 4°C, and 0.2 µm filtering the buffer to remove insoluble material. Protein was exchanged into digitonin buffer by gel filtration in a Superose 6 Increase column. Fractions containing LRRC8A channel were pooled and spin concentrated.

Electrophysiology {#s4-3}
-----------------

For proteoliposome patching experiments, we incorporated protein into lipid and generated proteoliposome blisters for patch recordings using dehydration and rehydration as described previously ([@bib4]; [@bib7]) with the following modifications. LRRC8A was first purified into Column Buffer with DDM/CHS at 0.025%/0.005%. Protein was then exchanged into lipid with the addition of Biobeads SM2 and an overnight incubation. Dried proteoliposomes in a dish were rehydrated overnight in a buffer containing 10 mM HEPES, 70 mM KCl, pH 7.4. The next day, the dish was filled with a bath solution containing 10 mM HEPES, 20 mM MgCl~2~, 30 mM KCl pH 7.4. The pipette solution was 10 mM HEPES, 70 mM KCl, pH 7.4. All experiments were conducted at room temperature.

Nanodisc formation {#s4-4}
------------------

Freshly purified LRRC8A from gel filtration in Buffer one was reconstituted into MSP1E3D1 nanodiscs with POPC lipid (Avanti, Alabaster, Alabama) at a final molar ratio of 1:2.5:250 (Monomer Ratio: LRRC8A, MSP1E3D1, POPC). First, solubilized lipid in Column Buffer (20 mM HEPES, 150 mM KCl, 1 mM EDTA pH 7.4) was mixed with additional DDM detergent, Column Buffer, and LRRC8A. This solution was mixed at 4°C for 30 min before addition of purified MSP1E3D1. This addition brought the final concentrations to approximately 10 µM LRRC8A, 25 µM MSP1E3D1, 2.5 mM POPC, and 4 mM DDM in Column Buffer. The solution with MSP1E3D1 was mixed at 4°C for 30 min before addition of 160 mg of Biobeads SM2 (Bio-Rad). Biobeads (washed into methanol, water, and then Column Buffer) were weighed with liquid removed by P1000 tip (Damp weight). This mix was incubated at 4°C for 30 min before addition of another 160 mg of Biobeads (final 320 mg of Biobeads per mL). This final mixture was then mixed at 4°C overnight (\~12 hr). Supernatant was cleared of beads by letting large beads settle and by 0.2 µm filtering. Sample was spun for 5 min at 21,000 x g before loading onto a Superose six column in Column Buffer. Peak fractions corresponding to LRRC8A in MSP1E3D1 were collected, 100 kDa cutoff spin concentrated, and then re-run on the Superose 6. The fractions corresponding to the center of the peak were then pooled and concentrated prior to grid preparation. For MSP2N2 nanodiscs, reconstitution was carried out with a molar ratio of 1:2:300 (Monomer Ratio: LRRC8A, MSP2N2, POPC (Avanti)). The final 1 mL reaction mix contained 5 µM LRRC8A monomer, 10 µM MSP2N2, 1.5 mM POPC,\~2.6 mM DDM, and 200 mg of Biobeads in Column Buffer. Column purification was performed similarly to the MSP1E3D1 preparation. Nanodisc proteins were prepared as described in [@bib25] and His-tags were cleaved with TEV protease.

Grid preparation {#s4-5}
----------------

For the MSP1E3D1 nanodisc samples, 100 µM of DCPIB (Tocris, Bristol, UK) was added to sample to give a final concentration of 0.8 mg/mL LRRC8A-MSP1E3D1. DCPIB was allowed to equilibrate and bind complex on ice for 1 hr prior to freezing grids. Sample with drug was cleared by a 5 min 21,000 x g spin prior to grid making. For freezing grids, a 3 µl drop of protein was applied to freshly glow discharged Holey Carbon, 400 mesh R 1.2/1.3 gold grids (Quantifoil, Großlöbichau, Germany). A FEI Vitrobot Mark IV (ThermoFisher Scientific) was utilized with 22°C, 100% humidity, one blot force, and a 3 s blot time, before plunge freezing in liquid ethane. Grids were then clipped in autoloader cartridges (FEI, Hillsboro, Oregon) and shipped in a dry shipper for data collection. The MSP2N2 sample was frozen without drug at 0.8 mg/mL with the same conditions as the MSP1E3D1 grids.

For the digitonin sample, purified protein was shipped in a refrigerated container. The next day, for freezing, a 3 µL drop of protein was applied to a freshly glow discharged Holey Carbon, 400 mesh R 1.2/1.3 gold grid (Quantifoil). A FEI Vitrobot Mark IV (ThermoFisher Scientific) was utilized with 22°C, 100% humidity, one blot force, and a 5 s blot time, before plunge freezing in liquid ethane. Grids were then clipped and used for data collection.

Cryo-EM data acquisition {#s4-6}
------------------------

For the digitonin-solubilized channels in 150 and 600 mM KCl, grids were transferred to an FEI Titan Krios cryo-EM operated at an acceleration voltage of 300 kV. Images were recorded in an automated fashion with SerialEM ([@bib19]) with a defocus range of −1.2 \~ −2.5 µm over 8 s as 40 subframes with a Gatan K2 direct electron detector in super-resolution mode with a super-resolution pixel size of 0.544 Å. The electron dose was 8 e^-^/pixel/s at the detector level and total accumulated dose was 54 e^-^/Å^2^. For the digitonin-solublized channels in 70 mM KCl, grids were transferred to an FEI Titan Krios cryo-EM operated at an acceleration voltage of 300 kV. Images were recorded in an automated fashion with Leginon ([@bib28]) with a defocus range of −1.2 \~ −2.5 µm over 8 s as 40 subframes with a Gatan K2 direct electron detector in super-resolution mode with a super-resolution pixel size of 0.536 Å. The electron dose was 9 e^-^/pixel/s at the detector level and total accumulated dose was 55.6 e^-^/Å^2^. For MSP2N2 nanodisc-reconstituted samples, grids were transferred to an FEI Titan Krios cryo-EM operated at an acceleration voltage of 300 kV. Images were recorded in an automated fashion with Leginon with a defocus range of −1.2 \~ −2.5 µm over 10 s as 40 subframes with a Gatan K2 direct electron detector in super-resolution mode with a super-resolution pixel size of 0.536 Å.

The MSP1E3D1 nanodisc-reconstituted samples were recorded in two sessions. For the first session, grids were transferred to an FEI Titan Krios cryo-EM operated at an acceleration voltage of 300 kV. Images were recorded in an automated fashion with SerialEM with a defocus range of −1.2 \~ −2.5 µm over 8 s as 40 subframes with a Gatan K2 direct electron detector in super-resolution mode with a super-resolution pixel size of 0.544 Å. The electron dose was 9 e^-^/pixel/s at the detector level and total accumulated dose was 60.8 e^-^/Å^2^. For the second session, grids were transferred to an FEI Titan Krios cryo-EM operated at an acceleration voltage of 300 kV. Images were recorded in an automated fashion with Leginon with a defocus range of −1.2 \~ −2.5 µm over 8 s as 40 subframes with a Gatan K2 direct electron detector in super-resolution mode with a super-resolution pixel size of 0.536 Å. The electron dose was 9 e^-^/pixel/s at the detector level and total accumulated dose was 55.6 e^-^/Å^2^. Also see [Tables 1](#table1){ref-type="table"} and [2.](#table2){ref-type="table"}

Cryo-EM data processing {#s4-7}
-----------------------

Processing was carried out using Relion 3.0 ([@bib36]; [@bib35]). Movies were gain and motion corrected with the Relion MotionCor2 package (standalone MotionCor2 for the digitonin datasets) ([@bib33]), and the data were binned to 1.088 Å/pixel. Ctf estimation was performed with Gctf 1.06. For particle picking, 1000--2000 particles were picked manually to generate references for autopicking. For the MSP1E3D1 and MSP2N2 Relion-3 processed datasets, 2x particle binning was performed at extraction for initial particle cleanup, before re-extraction to 1.088 Å/pixel for final classification and refinement. For the other datasets, particles were 2x binned for all processing steps except final 2D comparisons.

For the contracted and expanded LRRC8A states, we first noted differences in the linker region during initial full particle classing and blurred helical density in this region during full particle refinement. We therefore used a mask encompassing the linker region and the bottom of the transmembrane helices during classification without angular sampling to separate particles in these two classes. To obtain high-resolution particles for the final reconstruction, masking out the LRR region was crucial. For the final particle sets, we also performed unmasked refinement, which generated the full particle map shown in [Figure 1](#fig1){ref-type="fig"} for the contracted state. The full particles for the expanded state were consistently more difficult to refine to high resolution and also saw no benefit from Ctf Refinement, potentially due to their additional LRR heterogeneity.

For symmetry testing on the digitonin, MSP2N2, and MSP1E3D1 datasets, 2x binned particles (2.176 Å/pixel or 2.298 Å/pixel for MSP2N2) were first cleaned using 2D classification and 3D Classification using C1 symmetry with the same Gaussian filtered initial reference. For final symmetry analysis, three 3D Classifications were performed using the same reference and C1, C3, and C6 symmetry operations. For further comparison of digitonin and MSP2N2 particles, the best C1 classes were then used for final refinements in C3 and C6.

Overall resolution was estimated using Relion 3.0 and Phenix.mtriage. Local resolution was calculated using Relion. For a detailed pipeline see [Figure 1---figure supplements 3](#fig1s3){ref-type="fig"}--[10](#fig1s10){ref-type="fig"}.

Modeling and refinement {#s4-8}
-----------------------

Cryo-EM maps were sharpened using Phenix.autosharpen. The structures were modeled ab inito in Coot for all regions outside of the LRRs and refined in real space using Phenix.real_space_refine implementing Ramachandran and NCS restraints. Restraints for DCPIB and POPC ligands were generated using Phenix.elbow from SMILES string inputs and optimized with the eLBOW AM1 QM method. Validation tools in Phenix, EMRinger ([@bib2]), and Molprobity were used to guide two subsequent rounds of iterative manual adjustment in Coot and refinement in Phenix. For cross-validation, atoms in the final model were randomly displaced up to 0.5 Å and refined against one half-map ('work'). FSC curves were then calculated between the refined model and each half-map ('work' and 'free') using Phenix.mtriage. The absence of significant differences between the FSC curves is indicates the model was not overfit to the original map. Superpositions with published LRRC8A-detergent structures, which were not used as guides during model building, also demonstrate good overall correspondence aside from symmetry and conformational changes. For illustration of average LRR position in [Figure 1](#fig1){ref-type="fig"}, the 1.8 Å crystal structure from PDB 6FNW was docked as a rigid body into unmasked maps using Phenix. Channel cavity measurements were made with HOLE implemented in Coot. Electrostastic potential was calculated using APBS-PDB2PQR ([@bib9]). Figures were prepared using PyMOL, Chimera, ChimeraX, Fiji, Prism, and Adobe Photoshop and Illustrator software.
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Data availability {#s7}
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Final maps of LRRC8A-DCPIB in MSPE3D1 nanodiscs have been deposited to the Electron Microscopy Data Bank under accession codes EMDB-0562 (masked constricted state), and EMDB-0563 (masked expanded state) and atomic coordinates have been deposited in the PDB under IDs 6NZW (constricted state) and 6NZZ (expanded state). The original micrograph movies have been deposited to EMPIAR under accession codes EMPIAR-10258 and EMPIAR-10259. The map of apo-LRRC8A in MSP2N2 nanodiscs in a constricted state has been deposited with EMDB accession code EMDB-0564 and coordinates deposited in the PDB with ID 6O00.

The following datasets were generated:

KernDMOhSHiteRKBrohawnSG2019Atomic coordinates (apo-LRRC8A in MSP2N2 nanodiscs constricted state)Protein Data Bank6O00

KernDMOhSHiteRK2019Final map of LRRC8A-DCPIB in MSP1E3D1 nanodiscs (masked constricted state)Electron Microscopy Data BankEMDB-0562

KernDMOhSHiteRKBrohawnSG2019Final map of LRRC8A-DCPIB in MSP1E3D1 nanodiscs (masked expanded state)Electron Microscopy Data BankEMDB-0563

KernDMOhSHiteRKBrohawnSG2019Atomic coordinates (LRRC8A-DCPIB in MSP1E3D1 nanodiscs constricted state)Protein Data Bank6NZW

KernDMOhSHiteRKBrohawnSG2019Atomic coordinates (LRRC8A-DCPIB in MSP1E3D1 nanodiscs expanded state)Protein Data Bank6NZZ

KernDM2019Final map of apo-LRRC8A in MSP2N2 nanodiscs (masked constricted state)Electron Microscopy Data BankEMDB-0564

DavidM KernSeCheolOhRichardK HiteStephenG Brohawn2019Original micrograph moviesElectron Microscopy Public Image ArchiveEMPIAR-10258

DavidM KernSeCheolOhRichardK HiteStephenG Brohawn2019Original micrograph moviesElectron Microscopy Public Image ArchiveEMPIAR-10259
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article \"Cryo-EM structures of the DCPIB-inhibited volume-regulated anion channel LRRC8A in lipid nanodiscs\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Kenton Swartz as the Reviewing Editor and Richard Aldrich as the Senior Editor. The following individual involved in review of your submission have agreed to reveal his identity: Roderick MacKinnon (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript Kern and colleagues use cryo-EM to determine the first inhibited structure of the volume regulated anion channel LRRC8A in lipid nanodiscs. These structures reveal two novel features of these channels: that the DCPIB inhibitor binds to the extracellular selectivity filter to sterically block permeation, and two novel conformations of the channel where the intracellular pore and linker are at different levels of constriction. The LCRR8A nanodisc structure presented here shows that the channel has 6-fold symmetric transmembrane region with heterogeneous LRRs rather than a trimer of dimers as seen in the detergent-bound structures. The authors propose that this different arrangement is due to the presence of lipids and to the different interactions of the protein with the environment. Interestingly, despite the conformational heterogeneity of the LRRs, the authors show that the linkers connecting the TM and these cytosolic domains adopt two distinct conformations suggesting a pathway for the allosteric activation of these channels in response to low salt conditions. Overall the manuscript is well written, the data robust and clearly described. The structures provide novel insights into the structural organization of the LRRC8A channels. Some of the description and interpretation needs further clarification.

Essential revisions:

1\) The separation of the constricted and expanded states is a major conclusion in this work. 3D classification with symmetry can potentially average away the true conformational differences and lead to wrong conclusion. Therefore, we would like to see 3D classification without symmetry also reach the same conclusion. Specifically, in Figure 1---figure supplement 4, the last classification \"Class3D with Bottom TM and linker mask\" can be done using an alternative strategy. After refinement of 129k particles into one volume with C6 symmetry (like the 3.7 Å map above), the particles can be symmetry expanded to 780k, followed by no alignment 3D classification (8-12 classes) without symmetry and with the current mask.

2\) Similarly, when drawing the important conclusion about the symmetry difference between the reconstructions of LRRC8A-1E3D1, LRRC8A in digitonin and LRRC8A-2N2 (Figure 4---figure supplement 2), we would also suggest first refining all good particles into one 3D reconstruction with C6 symmetry, symmetry expansion and then 3D classification without symmetry or alignment. In this way, the major conformers will appear with its original symmetry features.

3\) General question: what is the physiological significance of a channel that opens in 70 mM electrolyte? In several places the structure is discussed in the context of this property. Under what circumstances does this condition arise?

4\) Subsection "Structure of LRRC8A in lipid nanodiscs" third paragraph, the first paragraph of subsection "Constricted and expanded structures suggest a mechanism to relay conformational changes between an ionic strength sensor and channel gate" and Figure 3: The two structures are different but the change in pore diameter is small compared to the diameter of the pore in the constricted state. Do you think the structure represents an initial step in a larger conformational change? What (data) makes you think this is a functionally important structural difference?

5\) Second paragraph of subsection "DCPIB inhibits LRRC8A through a cork-in-bottle mechanism": Please clarify why the drug-free and drug-bound conditions (digitonin and nanodisc, respectively) are different. Do you have any data comparing structures under the same conditions? The fourth paragraph of subsection "Channel symmetry and heterogeneity of LRRs in nanodiscs" seems to suggest that you have drug-free structures in a MSP2N2 nanodisc. What does this show? We ask because sometimes density in the pore of an ion channel can be observed in some detergent/lipid systems and not in others. If structural data is available for the protein in nanodiscs without drug it would seem very important to include it in the present manuscript.

6\) Do mutational data (perhaps in the literature) support the observed drug binding site? It would be useful to let the reader know this while describing the chemical interactions and mechanism of block (second and third paragraphs of subsection "DCPIB inhibits LRRC8A through a cork-in-bottle mechanism") since the 6-fold axis has prevented you from being able to build the inhibitor into the density with much accuracy. If mutation experiments have not been carried out, we request that you include them to strengthen our confidence in the inhibitor model. It would also be interesting to consider undertaking ion competition experiments to test the proposed plugging mechanism.

7\) Results section: \"Movement of cytoplasmic regions, perhaps as a consequence reduced ionic strength, can thus be coupled to the N-terminal gating region and an expansion of the channel pore in a concerted fashion\". This is a fairly vague statement. What precisely do you mean by this? Please be more explicit. What does the structure tell you about ionic strength sensing? Do you think that high ionic strength solutions screen charges, permitting them to get closer, for example?

8\) Please clarify what you mean by the statement: \"The relatively modest (low μM) affinity of DCPIB for LRRC8 channels (Decher et al., 2001) is probably due to the small protein-DCPIB interface and lack of significant structural rearrangement in the selectivity filter upon binding.\" The small interface would favor low affinity. The lack of required rearrangement would favor high. What point are you trying to make?

9\) While enticing, the observed conformations do not provide a clear mechanistic link between the sensor for ionic strength and the observed conformational changes. Do the authors have any data to suggest that low salt favors the expanded conformation over the constricted one, or data showing how mutating residues in the linker region affect channel activation?

10\) The implications of the different structural arrangement of the TM and cytosolic domains are not explored. Do the authors have any data addressing the role of the interactions of lipids with the intersubunit interfaces, for example, by testing how different lipid compositions affect channel function and structure?

11\) The lack of conformational changes near the extracellular region between the constricted and expanded 3D reconstructions can be due to DCPIB binding. This possibility should be discussed.

10.7554/eLife.42636.sa2

Author response

> Essential revisions:
>
> 1\) The separation of the constricted and expanded states is a major conclusion in this work. 3D classification with symmetry can potentially average away the true conformational differences and lead to wrong conclusion. Therefore, we would like to see 3D classification without symmetry also reach the same conclusion. Specifically, in Figure 1---figure supplement 4, the last classification \"Class3D with Bottom TM and linker mask\" can be done using an alternative strategy. After refinement of 129k particles into one volume with C6 symmetry (like the 3.7 Å map above), the particles can be symmetry expanded to 780k, followed by no alignment 3D classification (8-12 classes) without symmetry and with the current mask.

We thank the reviewers for their suggestion. As requested, we performed masked 3D classification without symmetry following C6 refinement and symmetry expansion (Figure 4---figure supplement 3A). This procedure leads to the same conclusion that the particles can be separated into constricted and expanded states. Both states show approximate six-fold symmetry in the linker, transmembrane, and extracellular regions of the channel. Weaker density for one or two subunits within some classes generated from the 129K particle set (of which 60K contribute to the final reconstructions, see Figure 1---figure supplement 5) suggests that a small fraction of the particles may adopt asymmetric conformations. However, we have seen similar differences in the relative strength of subunits of asymmetric 3D classes of other symmetric protein complexes and the differences may instead be due to particle misalignment, low signal-to-noise particle images or extreme disorder of the LRR domains biasing the particle alignments. To further increase our confidence in the classifications, we also performed refinement of the final set of particles without symmetry imposed. This asymmetric refinement generated approximately six-fold symmetric constricted and expanded states consistent with our conclusions (Figure 4---figure supplement 3B).

> 2\) Similarly, when drawing the important conclusion about the symmetry difference between the reconstructions of LRRC8A-1E3D1, LRRC8A in digitonin and LRRC8A-2N2 (Figure 4---figure supplement 2), we would also suggest first refining all good particles into one 3D reconstruction with C6 symmetry, symmetry expansion and then 3D classification without symmetry or alignment. In this way, the major conformers will appear with its original symmetry features.

We performed this refinement with the LRRC8A-MSP2N2 and digitonin datasets and the results support the conclusions about symmetry differences we report (Figure 4---figure supplement 3A). We also refer to three reports of higher resolution reconstructions of LRRC8A in digitonin (Deneka et al., 2018; Kasuya et al., 2018; Kefauver et al., 2018a), which all reach similar conclusions to those presented here concerning the C3 symmetry of LRRC8A in detergent. Please see response to essential revision \#5 for details on additional analyses of the LRRC8A-MSP2N2 dataset included in this revision.

> 3\) General question: what is the physiological significance of a channel that opens in 70 mM electrolyte? In several places the structure is discussed in the context of this property. Under what circumstances does this condition arise?

We used 70 mM electrolyte in single channel recordings to robustly activate LRRC8A currents as has been reported in several other recent reports (Kasuya et al., 2018; Syeda et al., 2016; Deneka et al., 2018; Voets et al., 1999). Less dramatic reductions in ionic strength result in a lesser degree of activation in cells (Deneka et al., 2018). It is unknown what range of intracellular ionic strengths are physiologically relevant stimuli for this channel or generally under what circumstances these conditions arise, but experimental and modeling results are consistent with reduced intracellular ionic strength in response to hypoosmotic extracellular conditions activating LRRC8 channels (Voets et al., 1999).

> 4\) Subsection "Structure of LRRC8A in lipid nanodiscs" third paragraph, the first paragraph of subsection "Constricted and expanded structures suggest a mechanism to relay conformational changes between an ionic strength sensor and channel gate" and Figure 3: The two structures are different but the change in pore diameter is small compared to the diameter of the pore in the constricted state. Do you think the structure represents an initial step in a larger conformational change? What (data) makes you think this is a functionally important structural difference?

We are unable at this time to determine whether the conformational changes we observe are sufficient to gate the channel open or if they represent an initial step of a larger conformational change to open the channel. The reason for this is that the pore dimensions of the channel that we calculate do not account for volume occupied by the N-terminus (amino acids 1-14) of each subunit. These residues from all six subunits project into the pore and may form the channel gate, but are not resolved in our structures (or other structures of LRRC8A to date). The true pore diameter is therefore smaller by an unknown amount in both the constricted and expanded states. While the expansion we observe is potentially large enough to open a pore, experiments to resolve the conformation of the N-terminus in each state are required to determine whether it is sufficient to gate the channel.

> 5\) Second paragraph of subsection "DCPIB inhibits LRRC8A through a cork-in-bottle mechanism": Please clarify why the drug-free and drug-bound conditions (digitonin and nanodisc, respectively) are different. Do you have any data comparing structures under the same conditions? The fourth paragraph of subsection "Channel symmetry and heterogeneity of LRRs in nanodiscs" seems to suggest that you have drug-free structures in a MSP2N2 nanodisc. What does this show? We ask because sometimes density in the pore of an ion channel can be observed in some detergent/lipid systems and not in others. If structural data is available for the protein in nanodiscs without drug it would seem very important to include it in the present manuscript.

We agree with these points. In order to distinguish differences that are a consequence of drug binding from differences that are a consequence of different hydrophobic environments, we have improved our refinement of the LRRC8A-MSP2N2 without DCPIB dataset (by incorporating per-particle motion trajectories and CTF refinement) and include classification results and a reconstruction to 4.18 Å resolution in the revised manuscript (Figure 1---figure supplements 8-10). The results are consistent with our conclusions and are summarized as follows. Drug binding results in density modeled as DCPIB in the selectivity filter and an increase in the conformational space sampled by LRRs. DCPIB density is only observed in reconstructions of DCPIB-bound LRRC8A in nanodiscs, while reconstructions of apo-LRRC8A in nanodiscs and apo-LRRC8A in digitonin both lack this density. Three additional differences, unrelated to drug binding, are found between structures of LRRC8A determined in lipid nanodiscs and digitonin detergent. First, large scale differences in structural organization are observed. In lipid nanodiscs, LRRC8A is six-fold symmetric in the extracellular, transmembrane, and linker regions with asymmetric and structurally heterogeneous LRRs, while in digitonin LRRC8A is three-fold symmetric with compact LRRs. Second, in lipid nanodiscs, but not detergent, density consistent with lipid binding between subunit interfaces is observed. Third, in lipid nanodiscs, but not detergent, particles are distributed between well-resolved constricted and expanded states in roughly similar proportions. We hypothesize that the bound lipids in nanodiscs structures, which are apparently lost during detergent solubilization prior to structure determination in digitonin, account for these differences between nanodisc-embedded and detergent-solubilized structures.

> 6\) Do mutational data (perhaps in the literature) support the observed drug binding site? It would be useful to let the reader know this while describing the chemical interactions and mechanism of block (second and third paragraphs of subsection "DCPIB inhibits LRRC8A through a cork-in-bottle mechanism") since the 6-fold axis has prevented you from being able to build the inhibitor into the density with much accuracy. If mutation experiments have not been carried out, we request that you include them to strengthen our confidence in the inhibitor model. It would also be interesting to consider undertaking ion competition experiments to test the proposed plugging mechanism.

Yes. We have included a reference to mutational data reported by the Patapoutian and Ward groups (Kefauver et al., 2018) supporting the observed drug binding site. Mutation of the arginine in the extracellular selectivity filter of LRRC8A to phenylalanine (R103F) reduces the extent of extracellular ATP block of LRRC8AC heteromeric channels from 72% ± 2% to 2 ± 3%. The R103F mutation creates an apolar selectivity filter ring in these heteromeric channels because the residue corresponding to R103 in LRRC8A is a leucine in LRRC8C. This is consistent with our model of electrostatic interactions being an important determinant for binding of anionic blockers including DCPIB and ATP to this site. We agree that our model makes interesting predictions that could be tested by ion competition experiments, but prefer to include these in future work.

> 7\) Results section: \"Movement of cytoplasmic regions, perhaps as a consequence reduced ionic strength, can thus be coupled to the N-terminal gating region and an expansion of the channel pore in a concerted fashion\". This is a fairly vague statement. What precisely do you mean by this? Please be more explicit. What does the structure tell you about ionic strength sensing? Do you think that high ionic strength solutions screen charges, permitting them to get closer, for example?

We have clarified this idea to be more explicit in proposing possible mechanisms including charge screening and moved the sentence to the discussion. We have also emphasized that while the ionic strength sensor has been presumed to be an intracellular aspect of the channel, it is not known which residue(s) are involved and we can only speculate on possible mechanisms since the cytoplasmic LRRs and long cytoplasmic linkers are heterogenous and poorly resolved in our structures.

> 8\) Please clarify what you mean by the statement: \"The relatively modest (low μM) affinity of DCPIB for LRRC8 channels (Decher et al., 2001) is probably due to the small protein-DCPIB interface and lack of significant structural rearrangement in the selectivity filter upon binding.\" The small interface would favor low affinity. The lack of required rearrangement would favor high. What point are you trying to make?

We thank the reviewers for pointing out this editing mistake. The point was that despite a rigid binding site, the interface is small and binding is therefore weak. We add that development of higher affinity and subunit selective blockers might be achieved by increasing the size and complementarity of the interaction surface.

> 9\) While enticing, the observed conformations do not provide a clear mechanistic link between the sensor for ionic strength and the observed conformational changes. Do the authors have any data to suggest that low salt favors the expanded conformation over the constricted one, or data showing how mutating residues in the linker region affect channel activation?

We agree with the reviewers and do not have these data, so we are careful to point out this out in the Discussion.

> 10\) The implications of the different structural arrangement of the TM and cytosolic domains are not explored. Do the authors have any data addressing the role of the interactions of lipids with the intersubunit interfaces, for example, by testing how different lipid compositions affect channel function and structure?

The major differences that we report are a result of varied hydrophobic environments between the structures reported here in lipid nanodiscs and those reported previously in digitonin. Since we are not able to assay channel function in detergent, we are unable to assess the functional implications of these differences at this time. We agree the effect of different lipid compositions on channel function will be interesting to pursue. We prefer to include it in later, systematic study. One reason for this is that the functional consequences of varying lipid compositions are difficult to predict from our structures because the lipid interactions observed are between lipid hydrocarbon tails and hydrophobic surfaces of the channel.

> 11\) The lack of conformational changes near the extracellular region between the constricted and expanded 3D reconstructions can be due to DCPIB binding. This possibility should be discussed.

We conclude that the conformation near the extracellular region in the constricted state is not strongly influenced by drug binding, since the constricted structures in MSPE3D1 with DCPIB and MSP2N2 without DCPIB are indistinguishable in this region (Figure 1---figure supplement 10D). The structure of this region is also very similar in apo-LRRC8A structures in digitonin. However, we cannot rule out that the structure of the extracellular region in the expanded state is influenced by drug binding as we were not able to resolve an expanded structure in MSP2N2 nanodiscs without DCPIB to high resolution.
